AIMS: The prognostic role of inflammation in peripheral arterial disease (PAD) remains to be conclusively established. Accordingly, in these patients we investigated the impact of myeloperoxidase (MPOx) and C-reactive protein on the incidence of myocardial infarction and stroke. METHODS AND RESULTS: Of 156 PAD patients, 10 had a myocardial infarction and seven a stroke, during follow-up. We used the receiver operating characteristic curve analysis and the bootstrap approach to identify the MPOx, C-reactive protein, and ankle brachial index (ABI) threshold levels that provided the best cut-off to predict the outcome. For MPOx a cut-off > or =183.7 pM was independently associated with a poor outcome (HR = 6.80, 95% CI 1.20-38.69, P = 0.031). The result remained unmodified when MPOx was used as a continuous variable (HR = 1.03, 95% CI 1.01-1.05, P = 0.031). Conversely, C-reactive protein was not a prognostic determinant in our series (HR = 0.88, 95% CI 0.60-1.29, P = 0.514). Kaplan-Meier curves for the four groups of patients delineated according to ABI and MPOx values identified using the bootstrap approach showed that the addition of MPOx measurement to ABI improved the ability to identify patients at risk for myocardial infarction and stroke. CONCLUSION: In PAD, MPOx, but not C-reactive protein, predicts an increased risk of major cardiovascular events, and adds to the prognostic value of ABI, currently the most powerful prognostic indicator in these patients.

Myeloperoxidase, but not C-reactive protein, predicts cardiovascular risk in peripheral arterial disease / Brevetti, Gregorio; Schiano, Vittorio; Laurenzano, Eugenio; Giugliano, Giuseppe; Petretta, Mario; Scopacasa, FRANCESCO UMBERTO VITTOR; Chiariello, Massimo. - In: EUROPEAN HEART JOURNAL. - ISSN 0195-668X. - STAMPA. - 29:2(2008), pp. 224-230.

Myeloperoxidase, but not C-reactive protein, predicts cardiovascular risk in peripheral arterial disease.

BREVETTI, GREGORIO;SCHIANO, VITTORIO;LAURENZANO, EUGENIO;GIUGLIANO, GIUSEPPE;PETRETTA, MARIO;SCOPACASA, FRANCESCO UMBERTO VITTOR;CHIARIELLO, MASSIMO
2008

Abstract

AIMS: The prognostic role of inflammation in peripheral arterial disease (PAD) remains to be conclusively established. Accordingly, in these patients we investigated the impact of myeloperoxidase (MPOx) and C-reactive protein on the incidence of myocardial infarction and stroke. METHODS AND RESULTS: Of 156 PAD patients, 10 had a myocardial infarction and seven a stroke, during follow-up. We used the receiver operating characteristic curve analysis and the bootstrap approach to identify the MPOx, C-reactive protein, and ankle brachial index (ABI) threshold levels that provided the best cut-off to predict the outcome. For MPOx a cut-off > or =183.7 pM was independently associated with a poor outcome (HR = 6.80, 95% CI 1.20-38.69, P = 0.031). The result remained unmodified when MPOx was used as a continuous variable (HR = 1.03, 95% CI 1.01-1.05, P = 0.031). Conversely, C-reactive protein was not a prognostic determinant in our series (HR = 0.88, 95% CI 0.60-1.29, P = 0.514). Kaplan-Meier curves for the four groups of patients delineated according to ABI and MPOx values identified using the bootstrap approach showed that the addition of MPOx measurement to ABI improved the ability to identify patients at risk for myocardial infarction and stroke. CONCLUSION: In PAD, MPOx, but not C-reactive protein, predicts an increased risk of major cardiovascular events, and adds to the prognostic value of ABI, currently the most powerful prognostic indicator in these patients.
2008
Myeloperoxidase, but not C-reactive protein, predicts cardiovascular risk in peripheral arterial disease / Brevetti, Gregorio; Schiano, Vittorio; Laurenzano, Eugenio; Giugliano, Giuseppe; Petretta, Mario; Scopacasa, FRANCESCO UMBERTO VITTOR; Chiariello, Massimo. - In: EUROPEAN HEART JOURNAL. - ISSN 0195-668X. - STAMPA. - 29:2(2008), pp. 224-230.
File in questo prodotto:
File Dimensione Formato  
Petretta Eur H J 2008 374033.pdf

non disponibili

Tipologia: Documento in Post-print
Licenza: Accesso privato/ristretto
Dimensione 141.09 kB
Formato Adobe PDF
141.09 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/374033
Citazioni
  • ???jsp.display-item.citation.pmc??? 20
  • Scopus 57
  • ???jsp.display-item.citation.isi??? 53
social impact